Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Prostatic Hyperplasia MeSH Descriptor Data 2026


MeSH Heading
Prostatic Hyperplasia
Tree Number(s)
C12.100.500.565.500
C12.200.294.565.500
Unique ID
D011470
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D011470
Annotation
note category: non-neoplastic despite entry terms ADENOMA, PROSTATIC, and PROSTATIC ADENOMA
Scope Note
Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both.
Entry Term(s)
Adenoma, Prostatic
Benign Prostatic Hyperplasia
Prostatic Adenoma
Prostatic Hyperplasia, Benign
Prostatic Hypertrophy
Prostatic Hypertrophy, Benign
NLM Classification #
WP 944
See Also
Prostatic Neoplasms
Prostatism
Public MeSH Note
96; was PROSTATIC HYPERTROPHY 1963-95; PROSTATIC HYPERPLASIA was see PROSTATIC HYPERTROPHY 1992-95
History Note
96; was PROSTATIC HYPERTROPHY 1963-95; PROSTATIC HYPERPLASIA was see PROSTATIC HYPERTROPHY 1992-95
Date Introduced
1996/01/01
Last Updated
2021/06/07
Prostatic Hyperplasia Preferred
Adenoma, Prostatic Related
Prostatic Hypertrophy Related
Benign Prostatic Hyperplasia Related
page delivered in 0.153s